1. Home
  2. DHIL vs EMBC Comparison

DHIL vs EMBC Comparison

Compare DHIL & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diamond Hill Investment Group Inc.

DHIL

Diamond Hill Investment Group Inc.

N/A

Current Price

$171.56

Market Cap

463.8M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.93

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHIL
EMBC
Founded
1990
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
521.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
DHIL
EMBC
Price
$171.56
$8.93
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
16.8K
834.2K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
3.48%
6.78%
EPS Growth
14.37
20.90
EPS
17.91
0.74
Revenue
$145,201,729.00
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$9.64
$11.96
Revenue Growth
6.69
N/A
52 Week Low
$114.11
$8.47
52 Week High
$173.70
$15.55

Technical Indicators

Market Signals
Indicator
DHIL
EMBC
Relative Strength Index (RSI) 54.17 40.80
Support Level $171.96 $8.60
Resistance Level $173.56 $9.47
Average True Range (ATR) 0.66 0.38
MACD -0.13 0.06
Stochastic Oscillator 35.96 40.70

Price Performance

Historical Comparison
DHIL
EMBC

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: